Project Number 1R21AG075656-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Alzheimer’s Disease Protection by Reduced Adenylyl Cyclase Type 5 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 13. Molecular Mechanisms of Neuroprotection and Resilience Researcher and Organization Principal Investigator VATNER, STEPHEN F Principal Investigator First Name STEPHEN F Principal Investigator Last Name VATNER Awardee Organization RUTGERS BIOMEDICAL AND HEALTH SCIENCES Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-195: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $431,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official NEWMAN, ELIZABETH
